Replies to post #7641 on AEterna Zentaris Inc. (AEZS)

[~ Blue ~]

University of Texas Southwestern Medical Center: "Recently, UT Southwestern participated in a study of a drug called zoptarelin doxorubicin that is expected to be the first FDA-approved drug for endometrial cancer"


Under
Access to the latest treatment

http://www.utswmedicine.org/cancer/programs/gynecologic/

FROM AEZS WEBSITE: Zoptarelin Doxorubicin Endometrial cancer

http://www.aezsinc.com/en/page.php?p=31&prod=87